0001213900-23-060425.txt : 20230728 0001213900-23-060425.hdr.sgml : 20230728 20230728075431 ACCESSION NUMBER: 0001213900-23-060425 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230721 FILED AS OF DATE: 20230728 DATE AS OF CHANGE: 20230728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daewoong Co., Ltd CENTRAL INDEX KEY: 0001985493 STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40021 FILM NUMBER: 231120238 BUSINESS ADDRESS: STREET 1: 244, GALMACHI-RO, JUNGWON-GU CITY: SEONGNAM-SI, GYEONGGI-DO STATE: M5 ZIP: 13211 BUSINESS PHONE: 82-2-550-8800 MAIL ADDRESS: STREET 1: 244, GALMACHI-RO, JUNGWON-GU CITY: SEONGNAM-SI, GYEONGGI-DO STATE: M5 ZIP: 13211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEON Biopharma, Inc. CENTRAL INDEX KEY: 0001837607 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853940478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 354-6499 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: Priveterra Acquisition Corp. DATE OF NAME CHANGE: 20201222 3 1 ownership.xml X0206 3 2023-07-21 0 0001837607 AEON Biopharma, Inc. AEON 0001985493 Daewoong Co., Ltd 244, GALMACHI-RO, JUNGWON-GU SEONGNAM-SI, GYEONGGI-DO M5 13211 KOREA, REPUBLIC OF 0 0 1 0 Common Stock, $0.0001 par value per share 4177604 D Common Stock, $0.0001 par value per share 2400000 I Indirect Beneficial Ownership in the 2,400,000 owned by Daewoong Pharmaceutical Co., Ltd Daewoong Co., Ltd., a company organized under the laws of the Republic of Korea, owns 51% of the outstanding shares of Daewoong Pharmaceutical Co., Ltd., a company organized under the laws of the Republic of Korea; Daewoong Co., Ltd. has voting power and dispositive power over Daewoong Pharmaceutical Co., Ltd. and therefore may be deemed to indirectly own such shares. Daewoong Co., Ltd., By: /s/ Kyu Sung Lim, Authorized Signatory 2023-07-28